RCS-21

N/A

Report date: 2025/03/04 20:00:11
NMEFirst In Class

Base Information

Drug NameRCS-21
Drug Alias NameRCS-21
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > microRNA
Mechanisms of ActionmicroRNA 21 inhibitors
TargetsmicroRNA 21
Therapy Area/IndicationsPulmonary FibrosisPneumonia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesRnatics GmbH
China Registration ClassN/A

Develop Information

Active CompaniesRnatics GmbH
Inactive CompaniesN/A
Active IndicationsPulmonary FibrosisPneumonia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A